Related Experiment Video
Updated: Jul 8, 2025

12:34
DNA Methylation: Bisulphite Modification and Analysis
Published on: October 21, 2011
105.0K
Ultrasensitive and Quantitative DNA Methylation Detection Method Based on the MutS Protein
Lei Zhang1, Wei Zhang2, Yaoqin Mu1
1Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, P.R. China.
Analytical Chemistry
|December 11, 2023
Summary
A new DNA methylation detection method, MutS-based methylation-specific PCR (MB-MSP), offers a simple, rapid, and highly sensitive approach for cancer diagnosis. This technique accurately detects methylated genes in plasma DNA, showing significant potential for early cancer detection.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- DNA methylation plays a critical role in cancer development and progression.
- Accurate detection of DNA methylation is essential for cancer diagnosis, prognosis, and monitoring treatment efficacy.
- Existing methods for DNA methylation detection often lack simplicity, speed, or high sensitivity and specificity.
Purpose of the Study:
- To develop a novel, simple, rapid, highly sensitive, and specific method for quantitative DNA methylation detection at specific sites.
- To introduce MutS-based methylation-specific PCR (MB-MSP) as an advanced tool for DNA methylation analysis.
- To evaluate the clinical applicability of MB-MSP for early cancer diagnosis.
Main Methods:
- Developed MutS-based methylation-specific PCR (MB-MSP) by leveraging the MutS protein's ability to bind mismatched base pairs.
- Inhibited amplification of unmethylated DNA and nonspecific primer amplification using the MutS mechanism.
- Quantitatively detected DNA methylation in specific genes (ACP1, CLEC11A, SEPT9) and validated in plasma-circulating tumor DNA.
Main Results:
- Achieved a detection sensitivity of 0.5% for methylated genes.
- Demonstrated a good linear relationship for quantitative detection.
- MB-MSP required only 1.5 hours for detection.
- Clinical validation on plasma DNA from liver cancer patients and healthy individuals yielded a 100% accuracy rate.
Conclusions:
- MB-MSP is a novel, reliable, and broadly applicable DNA methylation detection tool.
- The method exhibits significant advantages in simplicity, speed, specificity, and sensitivity.
- MB-MSP holds substantial potential for advancing early cancer diagnosis and clinical applications.

